Published in Gene Therapy Weekly, June 15th, 2006
"In previous study, we have shown that GaIT V functions as a positive growth regulator in glioma. Here, we reported that down-regulation of the expression of GaIT V in SHG44 cells by transfection with antisense cDNA specifically up-regulated the expression of cell surface integrin beta I without the change of its mRNA, and with integrin beta 1 125 kDa mature form increased and 105 kDa precursor form decreased," wrote X.N. Chen and colleagues, Fudan University.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.